Literature DB >> 11593102

The impaired glutathione system and its up-regulation by sulforaphane in vascular smooth muscle cells from spontaneously hypertensive rats.

L Wu1, B H Juurlink.   

Abstract

The glutathione (GSH) system plays an important role in reducing oxidative stress, the increase of which has been linked to the pathogenesis of hypertension. The aims of this study were to investigate: (1) whether the GSH system was impaired in aortic smooth muscle cells (SMCs) from spontaneously hypertensive rats (SHR), and (2) whether this system could be up-regulated by the phase-2 enzyme inducers, sulforaphane and t-butylhydroquinone (t-BHQ). Basal levels of cellular GSH, GSH-reductase and GSH-peroxidase were significantly lower in SMCs from SHR than from normotensive Wistar-Kyoto (WKY) rats. Heme oxygenase-1 (HO-1) was significantly higher in SHR SMCs, which correlated with the higher oxidative stress experienced by these cells. No differences were observed in the basal activity of GSH-S-transferase nor in the ability to synthesize GSH between SMCs from these two strains. Sulforaphane (0.05-1 micromol/l) and t-BHQ (10-100 micromol/l) induced significant and concentration-dependent increases in cellular GSH levels, HO-1 protein content and activities of GSH-reductase and GSH-peroxidase in SMCs from both rat strains. Upregulation of phase 2 enzymes correlated with a decrease in oxidative stress experienced by the SMCs, particularly with SHR. We conclude that SHR SMCs experience greater oxidative stress than WKY SMCs and that malfunction of the GSH system contributes to the enhanced oxidative stress in SHR SMCs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11593102     DOI: 10.1097/00004872-200110000-00016

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  16 in total

Review 1.  Metabolic syndrome: pathophysiology, management, and modulation by natural compounds.

Authors:  Yogita Rochlani; Naga Venkata Pothineni; Swathi Kovelamudi; Jawahar L Mehta
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-06-22

2.  Sulforaphane as a Promising Natural Molecule for Cancer Prevention and Treatment.

Authors:  Osama A Elkashty; Simon D Tran
Journal:  Curr Med Sci       Date:  2021-04-20

3.  Sulforaphane inhibits platelet-derived growth factor-induced vascular smooth muscle cell proliferation by targeting mTOR/p70S6kinase signaling independent of Nrf2 activation.

Authors:  Noha M Shawky; Lakshman Segar
Journal:  Pharmacol Res       Date:  2017-02-14       Impact factor: 7.658

4.  Role of methylglyoxal in essential hypertension.

Authors:  Sudesh Vasdev; Jennifer Stuckless
Journal:  Int J Angiol       Date:  2010

5.  Effect of Dietary Doses of Quercetin on Hepatic Drug Metabolizing Enzymes in Spontaneously Hypertensive Rats.

Authors:  Fawzy Elbarbry; Aimy Ung; Deepa Rao; Khaled Abdelkawy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-12       Impact factor: 2.441

6.  New Insights into the Pathogenesis of Preeclampsia - The Role of Nrf2 Activators and their Potential Therapeutic Impact.

Authors:  N Kweider; C J Wruck; W Rath
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-12       Impact factor: 2.915

7.  Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system.

Authors:  Lingyun Wu; M Hossein Noyan Ashraf; Marina Facci; Rui Wang; Phyllis G Paterson; Alison Ferrie; Bernhard H J Juurlink
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-21       Impact factor: 11.205

8.  Sulforaphane improves dysregulated metabolic profile and inhibits leptin-induced VSMC proliferation: Implications toward suppression of neointima formation after arterial injury in western diet-fed obese mice.

Authors:  Noha M Shawky; Prahalathan Pichavaram; George S G Shehatou; Ghada M Suddek; Nariman M Gameil; John Y Jun; Lakshman Segar
Journal:  J Nutr Biochem       Date:  2016-03-10       Impact factor: 6.048

9.  The influence of sulforaphane on vascular health and its relevance to nutritional approaches to prevent cardiovascular disease.

Authors:  Paul C Evans
Journal:  EPMA J       Date:  2011-02-12       Impact factor: 6.543

10.  Different effects of angiotensin converting enzyme inhibitors on endothelin-1 and nitric oxide balance in human vascular endothelial cells: evidence of an oxidant-sensitive pathway.

Authors:  Giovambattista Desideri; Davide Grassi; Giuseppe Croce; Raffaella Bocale; Sergio Tiberti; Stefano Evangelista; Stefano Necozione; Ferdinando Di Orio; Claudio Ferri
Journal:  Mediators Inflamm       Date:  2008-12-01       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.